Literature DB >> 21402541

Hide and seek... Can we eradicate HIV by treatment intensification?

Julian Schulze zur Wiesch, Jan van Lunzen.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21402541     DOI： 10.1093/infdis/jiq150

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Feasibility and potential role of ferumoxytol-enhanced neuroimaging in HIV-associated neurocognitive disorder.

Authors:  Beau K Nakamoto; Cecilia M Shikuma; Debra Ogata-Arakaki; Tracie Umaki; Edward A Neuwelt; Bruce T Shiramizu; Dominic C Chow; Nisha I Parikh; Kalpana J Kallianpur; Bronwyn E Hamilton
Journal:  J Neurovirol       Date:  2013-10-16       Impact factor: 2.643

2.  Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy.

Authors:  B Shiramizu; J Ananworanich; T Chalermchai; U Siangphoe; D Troelstrup; C Shikuma; V De Grutolla; P Sithinamsuwan; P Praihirunkit; S Rattanamanee; V Valcour
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

Review 3.  Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection.

Authors:  Barna Dey; Edward A Berger
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

Review 4.  Paediatric HIV infection: the potential for cure.

Authors:  Philip J Goulder; Sharon R Lewin; Ellen M Leitman
Journal:  Nat Rev Immunol       Date:  2016-03-14       Impact factor: 53.106

5.  Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice.

Authors:  Ilona Hauber; Helga Hofmann-Sieber; Jan Chemnitz; Danilo Dubrau; Janet Chusainow; Rolf Stucka; Philip Hartjen; Axel Schambach; Patrick Ziegler; Karl Hackmann; Evelin Schröck; Udo Schumacher; Christoph Lindner; Adam Grundhoff; Christopher Baum; Markus G Manz; Frank Buchholz; Joachim Hauber
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.